The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptideAlzheimer's disease amyloid-beta links lens and brain pathology in Down syndromeChronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model.The genetic epidemiology of neurodegenerative disease.Evaluation of the potential excess of statistically significant findings in published genetic association studies: application to Alzheimer's diseaseIron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's diseaseAlzheimer's disease-associated ubiquilin-1 regulates presenilin-1 accumulation and aggresome formationAssessment of Alzheimer's disease case-control associations using family-based methodsInsulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivoAlzheimer's in 3D culture: challenges and perspectivesPotential use of γ-secretase modulators in the treatment of Alzheimer diseaseA γ-secretase inhibitor, but not a γ-secretase modulator, induced defects in BDNF axonal trafficking and signaling: evidence for a role for APPMapping autism risk loci using genetic linkage and chromosomal rearrangements.A Circadian Clock Gene, Cry, Affects Heart Morphogenesis and Function in Drosophila as Revealed by Optical Coherence MicroscopyOptogenetic pacing in Drosophila melanogasterRarity of the Alzheimer disease-protective APP A673T variant in the United States3D culture models of Alzheimer's disease: a road map to a "cure-in-a-dish"Alzheimer's disease: the cholesterol connectionGeneration of the beta-amyloid peptide and the amyloid precursor protein C-terminal fragment gamma are potentiated by FE65L1Family-based association between Alzheimer's disease and variants in UBQLN1Association between microdeletion and microduplication at 16p11.2 and autismSystematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene databaseDecreased catalytic activity of the insulin-degrading enzyme in chromosome 10-linked Alzheimer disease familiesSystematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene databasePeripheral surgical wounding and age-dependent neuroinflammation in miceThe zinc dyshomeostasis hypothesis of Alzheimer's diseaseCommon variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.A Multidisciplinary Approach to Mind and ConsciousnessComprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database.The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study.Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association studyProtein aggregates and novel presenilin gene variants in idiopathic dilated cardiomyopathyAge-dependent postoperative cognitive impairment and Alzheimer-related neuropathology in mice.Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease.The LDLR locus in Alzheimer's disease: a family-based study and meta-analysis of case-control data.Metal exposure and Alzheimer's pathogenesis.GENETICS. The Human Variome ProjectModulation of gamma-secretase reduces beta-amyloid deposition in a transgenic mouse model of Alzheimer's disease.Evidence of altered posteromedial cortical FMRI activity in subjects at risk for Alzheimer diseaseLoss of function of ATXN1 increases amyloid beta-protein levels by potentiating beta-secretase processing of beta-amyloid precursor protein.
P50
Q21090025-B73E7943-2AEC-4670-8D50-41E0E0F93D6CQ21136371-B65DB927-3F8B-4532-98B1-5E9166B55360Q22242243-7593D8D7-4792-4B3E-BD8A-5DD9CE13513CQ22306301-1906A40C-7338-48F2-9C23-EA87398645CAQ24289214-E52D72FE-D9D6-4F25-8418-96B6CD3F6CD5Q24298553-DF8188A4-1F80-44B9-A830-EE9DC6E67159Q24314297-BDB5A836-30D1-450E-BC89-B16D889BA658Q24622654-C66C8685-CA3B-4BC5-9763-8AAC9D5770C0Q24683214-D3734C19-3A3A-458A-A675-1A2E5766BBF2Q26801081-A47BEDE6-F157-46A1-B236-616AF9475272Q27004876-265FA363-CE89-4181-9A1E-A5CFFA85C7DEQ27314017-D3716FF8-1C15-4FBC-BF93-9335B49ED509Q27315912-A118D29D-6C6C-417A-9135-DFBD48387208Q27319835-AA4F60B3-936C-40E1-832E-751507F21FFBQ27339316-B429F807-1912-4276-BD3F-0CD66E74E77BQ27346292-F0AD14A8-59CB-4FA4-9B97-E0FC36B64296Q28078900-EA467024-053A-4DF5-A588-E481664AED8DQ28186482-3606411A-727F-4897-8E06-C4BF2B50B950Q28207449-E22BEFB9-BA62-4D04-9621-5649759405ADQ28237933-097E0A09-CD95-4A1F-BCD0-D462ECB539EBQ28264205-9B719A77-4BC3-4C59-98FB-E0D38A4D3C28Q28280965-330BE3C3-9D41-43E2-8B32-938B78A580A1Q28284636-457C8362-C343-41B4-BE9F-ED54AA50AEC1Q28285397-EDE36428-F59D-4C02-AEAB-AB9092BCFDF1Q28538508-95C4F4C2-65B0-4B1E-933D-8661B8A9EE9BQ28730954-2E6C5720-AFF8-442D-88C9-6F88C01BC762Q28943325-B49C7395-A096-43F6-AB65-D19D39F8C051Q29392906-8936F72A-1CEE-40AA-B86F-33388F1B93B8Q29417106-929ECEDD-AF30-41B6-992D-B212FDF2EA85Q30433658-F5C0E7E2-8E2D-446B-8368-C35F97D4B5A1Q30459046-A72645A1-1FE1-4081-B0D9-001F84E037C6Q30493863-EC08BFDF-3414-471B-848E-4384914C318BQ30565656-3D9FBA3D-2151-47BE-858A-4C1954E048B1Q30725675-363FE62F-E72D-43EB-B53A-EED0E23497D5Q31027649-A05CEEB7-877D-4C65-8044-B49A860427F4Q33234815-233BE629-9D62-4E54-A88B-5ABA9788A95AQ33608598-CCE8CB89-2882-4601-A39E-64C1855650F1Q33687945-71D7D665-56EB-411D-BA12-D2A03A842FB1Q33721909-74D0BDB6-9952-48A9-8A2F-D3CECA343B0BQ33726336-1AE01FF0-DD83-489F-A052-AAFA8B246564
P50
description
neurologist
@en
neuroloog
@nl
name
Rudolph E. Tanzi
@ast
Rudolph E. Tanzi
@en
Rudolph E. Tanzi
@es
Rudolph E. Tanzi
@ga
Танзи, Рудольф
@ru
type
label
Rudolph E. Tanzi
@ast
Rudolph E. Tanzi
@en
Rudolph E. Tanzi
@es
Rudolph E. Tanzi
@ga
Танзи, Рудольф
@ru
altLabel
Рудольф Танзи
@ru
prefLabel
Rudolph E. Tanzi
@ast
Rudolph E. Tanzi
@en
Rudolph E. Tanzi
@es
Rudolph E. Tanzi
@ga
Танзи, Рудольф
@ru
P1006
P214
P2163
P244
P1006
P101
P166
P19
P21
P213
0000 0001 1658 9583
P214
P2163
P2381
P244
P31
P373
Rudolph E. Tanzi
P569
1958-01-01T00:00:00Z